Director, Global Diagnostic Strategy Lead; DxSL
-
Business
Job Description & How to Apply Below
Career Category
Research
Job Description
At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do.
Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year. Amgen is advancing a broad and deep pipeline of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases, and obesity and obesity‑related conditions.
As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives.
Our award‑winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.
What you will do
Let’s do this. Let’s change the world.
In this vital role, the Director, Global Diagnostic Strategy Lead (DxSL) will lead the creation, alignment, and execution of comprehensive global diagnostic strategies for assigned molecules and programs within a disease area or therapeutic area. The DxSL serves as the primary diagnostic strategy point of contact for program teams and governance forums, helping ensure that diagnostic development plans enable clinical development, regulatory approval, launch, commercialization, and lifecycle management of precision therapeutics.
The DxSL leads through a matrix of scientific, clinical, regulatory, operational, quality, and external partner teams, with accountability for a coherent development path from early feasibility through validation, regulatory review, and post‑approval lifecycle activities.
The Diagnostics (Dx) Group is responsible for the successful transition of biomarker assays into marketed diagnostics that support therapeutic development strategy, regulatory approval, access, and commercialization.
- Develop and lead integrated, end-to‑end diagnostic strategies from early diagnostic need assessment through launch and lifecycle management.
- Partner with Product Teams, program leadership and other decision‑making forums, to align therapeutic and diagnostic development objectives.
- Evaluate and propose diagnostic strategic options, including assay and platform approaches, partner strategy, regulatory and commercial pathways, trade‑offs, opportunities, costs, timelines, and risks.
- Lead and oversee Dx Development Teams (DxDTs) to ensure tactical execution of the diagnostic development plan and alignment between Rx and Dx development programs.
- Influence decision‑making in a matrixed environment by communicating balanced, unbiased assessments of diagnostic opportunities and risks.
- Represent the Dx function with internal stakeholders and external diagnostic development partners.
- Manage, coach, and develop a team of Dx technical leads while delivering through cross‑functional leadership and influence.
- Assess biomarker biology, therapeutic mechanism, clinical context, and intended use to determine diagnostic needs and define the evidence required to support program decisions.
- Develop diagnostic target product profiles that describe intended use, target population, specimen type, analyte, performance goals, testing setting, and operational requirements.
- Recommend fit‑for‑purpose assay and platform approaches, which may include next‑generation…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
View / Apply for Jobs
Matching My Jurisdiction